Low RBM3 Protein Expression Correlates with Clinical Stage, Prognostic Classification and Increased Risk of Treatment Failure in Testicular Non-Seminomatous Germ Cell Cancer.

Research output: Contribution to journalArticle

Abstract

Expression of the RNA-binding motif protein 3 (RBM3) has been shown to correlate with favourable clinicopathological parameters and prognosis in several cancer diseases. The aim of this study was to examine the expression and prognostic ability of RBM3 in patients with testicular non-seminomatous germ cell tumours (NSGCT).

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Cancer and Oncology
Original languageEnglish
Article numbere0121300
JournalPLoS ONE
Volume10
Issue number3
Publication statusPublished - 2015
Publication categoryResearch
Peer-reviewedYes

Total downloads

No data available

Related research output

Olofsson, S-E., 2015, Oncology, MV. 105 p.

Research output: ThesisDoctoral Thesis (compilation)

View all (1)